Delivery Order V797D30042-36C26021F0264
Award Date
2/7/21
Potential Completion Date
2/6/22
Potential Value
$130K
Federal Agency
Veterans Integrated Service Network 20
Awardee
Grifols Therapeutics LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a firm-fixed-price delivery order to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals, for the provision of the drug PROLASTIN. The $114,000.00 order was placed against Grifols' contract under the General Services Administration (GSA) Pharmaceuticals and Drugs (FSS-61-IB) schedule. This award did not utilize any small business set-asides. Grifols has previously...
This contract award is for the pharmaceutical product PROLASTIN, provided by Grifols Therapeutics LLC, a for-profit manufacturer of pharmaceuticals and biopharmaceuticals. The contract, which does not utilize any set-asides, was awarded on October 19, 2018 by the Department of Veterans Affairs Veterans Health Administration for a total potential value of $100,131.84. The contract is a Blanket Purchase Agreement (BPA) call, with a firm-fixed price, and is associated with the Pharmaceuticals and...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Grifols Therapeutics LLC, a for-profit pharmaceutical manufacturer and supplier, for the provision of 1,000mg vials of the drug Prolastin. The potential value of this award is $310,527.76. The contract does not utilize any small business set-asides. This award is under the Pharmaceuticals and Drugs GSA Schedule 61 contract...
This federal contract award is for PROLASTIN-C, a pharmaceutical product, awarded by the Department of Veterans Affairs Veterans Health Administration to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The $355,273.02 firm fixed price delivery order is under the Pharmaceuticals and Drugs GSA Schedule contract vehicle and does not utilize any small business set-asides. Grifols Therapeutics has previously been awarded other federal...
The Department of Veterans Affairs Veterans Health Administration (VA VHA) awarded a firm fixed price delivery order contract for PROLASTIN C, a pharmaceutical product, to Grifols Therapeutics LLC, a for-profit limited liability company and manufacturer. The contract was awarded on October 1, 2021 with a potential value of $454,461.44 and a completion date of September 30, 2022. The contract was issued under the Pharmaceuticals and Drugs GSA Schedule, which is a government-wide acquisition...
This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The $98,175.36 firm-fixed-price delivery order is for the provision of various pharmaceutical products, including Prolastin, Prolastin-C, and immune globulin, to the VA's Integrated Service Network 19. The contract is a delivery order placed against the Pharmaceuticals and Drugs Federal Supply Schedule...
This is a federal contract award for the pharmaceutical product Prolastin, awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is a delivery order under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule, with a firm fixed price and a ceiling value of $162,548.16. This award does not utilize any small business set-asides. Grifols Therapeutics LLC...
This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals. The contract is for the supply of PROLASTIN-C PHARMACEUTICALS and is issued under the VA's Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB). The contract has a ceiling value of $94,800.00 and a period of performance ending on September 30, 2015. The contract does not utilize any small...
This federal contract award to Grifols USA LLC, a global healthcare company, is for the pharmaceutical product PROLASTIN-C LIQUID. The contract, valued at $11,502.40, is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 (VISN 5). PROLASTIN-C is an alpha1-proteinase inhibitor used to treat alpha1-antitrypsin deficiency. The contract has a firm fixed price and an ultimate completion date of August 23, 2024. Grifols USA LLC holds a Federal...
This is a federal contract award to Grifols Therapeutics LLC, a for-profit manufacturer and supplier of pharmaceuticals and biopharmaceuticals, to provide the pharmaceutical product Prolastin to the Department of Veterans Affairs (VA). The contract was issued as a Blanket Purchase Agreement (BPA) call under the Pharmaceuticals and Drugs General Services Administration (GSA) Schedule contract vehicle. The fixed-price contract has a ceiling value of $86,315.28 and a period of performance ending on...